For: | Yang J, Xu MQ, Yan LN, Chen XB, Liu J. Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol 2012; 18(27): 3537-3550 [PMID: 22826618 DOI: 10.3748/wjg.v18.i27.3537] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i27/3537.htm |
Number | Citing Articles |
1 |
Bin Liu, Jing Li, Lu-Nan Yan. Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/325318
|
2 |
Xiaohan Wang, Luoyan Ai, Qingqing Xu, Changwei Wu, Zhiwei Chen, Dazhi Su, Xiaoke Jiang, Zhuping Fan. A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses. Inflammation 2017; 40(3): 840 doi: 10.1007/s10753-017-0528-2
|
3 |
Peng Sheng Yi, Yan Shu, Wang Xiu Bi, Xiao Bo Zheng, Wan Jing Feng, Lin Ye He, Jian Shui Li. Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(12): 21479 doi: 10.1002/jcp.28877
|
4 |
Fu-Zhen Dai, Jie Yang, Xiao-Bo Chen, Ming-Qing Xu. Zinc finger protein A20 inhibits maturation of dendritic cells resident in rat liver allograft. Journal of Surgical Research 2013; 183(2): 885 doi: 10.1016/j.jss.2013.01.062
|
5 |
Cleide Gonçalves da Silva, Jesus Revuelta Cervantes, Peter Studer, Christiane Ferran. The Multiple Therapeutic Targets of A20. Advances in Experimental Medicine and Biology 2014; 809: 117 doi: 10.1007/978-1-4939-0398-6_8
|
6 |
María A. Jiménez-Sousa, Juan Berenguer, Amanda Fernández-Rodríguez, Luz María Medrano, Teresa Aldámiz-Echevarria, Leire Pérez-Latorre, Cristina Díez, María Martín-Vicente, Mónica Gutiérrez-Rivas, Isidoro Martínez, Salvador Resino. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study. Infection, Genetics and Evolution 2019; 67: 112 doi: 10.1016/j.meegid.2018.10.008
|
7 |
Xiaohan Wang, Feng Han, Yueyu Shen, Yunqing Chen, Zizhong Ji. A20 Attenuates Lipopolysaccharide-Induced Inflammation Through MAPK/ERK/JNK Pathway in LX-2 Cells. Hepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.114050
|
8 |
Nathan W. Zammit, Stacey N. Walters, Karen L. Seeberger, Philip J. O’Connell, Gregory S. Korbutt, Shane T. Grey. A20 as an immune tolerance factor can determine islet transplant outcomes. JCI Insight 2019; 4(21) doi: 10.1172/jci.insight.131028
|
9 |
Andreas Kommer, Myriam Meineck, Paul Classen, Julia Weinmann-Menke. A20 in Kidney Transplantation and Autoimmunity. International Journal of Molecular Sciences 2024; 25(12): 6628 doi: 10.3390/ijms25126628
|
10 |
Y.R. Kim, Y.S. Jung, Y.H. Lee, C.J. Hwang, J.L. Hwang, C.H. Seok, H.C. Seong, N.Y. Yoon, S.Y. Yeom, S.B. Han, D.Y. Yoon, J.T. Hong. IL-32γ Inhibits Acetaminophen-Induced Acute Hepatotoxicity through Inactivation of NF-κB and Stat1 Signals. European Journal of Inflammation 2013; 11(3): 663 doi: 10.1177/1721727X1301100310
|
11 |
Shu-Bei Cui, Tao-Xia Wang, Zhen-Wu Liu, Ji-Ying Yan, Kai Zhang. Zinc finger protein A20 regulates the development and progression of osteoarthritis by affecting the activity of NF-κB p65. Immunopharmacology and Immunotoxicology 2021; 43(6): 713 doi: 10.1080/08923973.2021.1970764
|